Get the Stockscreener App
1.17
0.43%
0.00
Rapt Therapeutics Inc Stock (RAPT) Forecast
The Rapt Therapeutics Inc (RAPT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $25.93, representing a +2,116% increase from the current price of $1.17. The highest analyst price target is $33.80, and the lowest is $18.05.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RAPT Price Target
Average 24.65
(+2,007% Upside)
Is Rapt Therapeutics Inc (RAPT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 50.68 | Neutral |
| STOCH(9,6) | 50.93 | Neutral |
| STOCHRSI(14) | 67.15 | Neutral |
| MACD(12,26) | -0.0111 | Buy |
| ADX(14) | 14.22 | Neutral |
| William %R | -48.08 | Neutral |
| CCI(14) | 52.53 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.1335
Buy
|
1.1555
Buy
|
| MA20 |
1.1587
Buy
|
1.1581
Buy
|
| MA50 |
1.2219
Sell
|
1.2201
Sell
|
| MA100 |
1.3671
Sell
|
1.5683
Sell
|
| MA200 |
2.0242
Sell
|
3.7515
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, RAPT could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on RAPT, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 50.68 indicates that RAPT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 50.93 indicates that RAPT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 67.15 indicates that RAPT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.22 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 52.53 indicates that RAPT is still overbought but not to an extreme extent.
Long-term RAPT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Rapt Therapeutics Inc financial reports and earnings history, Rapt Therapeutics Inc (RAPT) stock could reach $8.625 by 2030, $26.14 by 2040 and $6.8994 by 2050. See the projected annual prices until 2050 of the Rapt Therapeutics Inc stock below:
- Rapt Therapeutics Inc (RAPT) is expected to reach an average price of $3.2521 in 2035, with a high prediction of $7.7619 and a low estimate of $0.5282. This indicates an $177.96% rise from the last recorded price of $1.17.
- Rapt Therapeutics Inc (RAPT) stock is projected to chart a bullish course in 2040, with an average price target of $0.9987, representing an $-14.64% surge from its current level. The forecast ranges from a conservative $0.2713 to a sky-high $26.14.
- Our analysts predict Rapt Therapeutics Inc (RAPT) to jump 1,928% by 2045, soaring from $2.2447 to an average price of $23.73, potentially reaching $25.40. While $2.2447 is the low estimate, the potential upside is significant.
- Rapt Therapeutics Inc (RAPT) stock is expected to climb by 2050, reaching an average of $4.9189, a $320.42% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.8994 and $7.487, respectively, highlighting the market's uncertainty.
Rapt Therapeutics Inc Stock (RAPT) Year by Year Forecast
Rapt Therapeutics Inc Stock (RAPT) Price Forecast for 2025
Rapt Therapeutics Inc Stock (RAPT) is expected to reach an average price of $23.82 in 2025, with a high prediction of $37.42 and a low estimate of $10.22. This indicates an +1,936% rise from the last recorded price of $1.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $31.03 | $18.05 | $33.80 | +2,552% |
| May, 2025 | $26.33 | $22.32 | $33.81 | +2,150% |
| June, 2025 | $24.31 | $23.44 | $37.42 | +1,978% |
| July, 2025 | $17.26 | $10.22 | $30.96 | +1,375% |
| August, 2025 | $17.05 | $15.98 | $21.45 | +1,357% |
| September, 2025 | $16.59 | $14.34 | $17.64 | +1,318% |
| October, 2025 | $13.85 | $13.71 | $17.83 | +1,083% |
| November, 2025 | $17.55 | $10.59 | $20.72 | +1,400% |
| December, 2025 | $16.61 | $14.78 | $19.55 | +1,319% |
Rapt Therapeutics Inc Stock (RAPT) Price Forecast for 2026
The predicted value for Rapt Therapeutics Inc (RAPT) in 2026 is set at an average of $25.63. Estimates vary from a peak of $39.07 to a trough of $12.18, indicating an +2,090% surge from the present price of $1.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $14.46 | $13.45 | $18.98 | +1,136% |
| February, 2026 | $30.38 | $13.11 | $39.07 | +2,497% |
| March, 2026 | $29.57 | $25.85 | $32.40 | +2,427% |
| April, 2026 | $27.97 | $24.92 | $30.04 | +2,291% |
| May, 2026 | $31.91 | $25.07 | $32.38 | +2,627% |
| June, 2026 | $26.91 | $26.39 | $36.58 | +2,200% |
| July, 2026 | $27.53 | $25.23 | $29.31 | +2,253% |
| August, 2026 | $27.14 | $26.10 | $35.86 | +2,220% |
| September, 2026 | $32.64 | $24.56 | $32.90 | +2,689% |
| October, 2026 | $17.04 | $16.01 | $36.77 | +1,357% |
| November, 2026 | $17.86 | $14.74 | $20.52 | +1,427% |
| December, 2026 | $20.09 | $12.18 | $21.10 | +1,617% |
Rapt Therapeutics Inc Stock (RAPT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Rapt Therapeutics Inc (RAPT) is $17.38, with a high forecast of $28.73 and a low forecast of $6.0256. This indicates an +1,385% increase from the last price of $1.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $18.97 | $16.62 | $20.59 | +1,521% |
| February, 2027 | $11.29 | $10.93 | $20.74 | +864.72% |
| March, 2027 | $10.91 | $6.0256 | $12.08 | +832.54% |
| April, 2027 | $15.41 | $9.5208 | $15.90 | +1,217% |
| May, 2027 | $17.13 | $13.38 | $18.48 | +1,364% |
| June, 2027 | $22.97 | $13.54 | $26.45 | +1,863% |
| July, 2027 | $22.48 | $18.85 | $28.73 | +1,822% |
| August, 2027 | $18.88 | $17.93 | $24.07 | +1,514% |
| September, 2027 | $16.81 | $16.03 | $19.98 | +1,337% |
| October, 2027 | $14.07 | $13.32 | $21.02 | +1,103% |
| November, 2027 | $13.58 | $11.99 | $15.59 | +1,061% |
| December, 2027 | $24.41 | $13.03 | $27.11 | +1,986% |
Rapt Therapeutics Inc Stock (RAPT) Price Forecast for 2028
In 2028, Rapt Therapeutics Inc (RAPT) is projected to reach an average price of $17.59, with a high projection of $27.95 and a low estimate of $7.2363. This indicates an +1,404% rise from the last price of $1.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $26.06 | $22.59 | $26.83 | +2,127% |
| February, 2028 | $21.21 | $20.60 | $27.95 | +1,712% |
| March, 2028 | $13.31 | $12.32 | $23.27 | +1,037% |
| April, 2028 | $15.55 | $13.82 | $17.25 | +1,229% |
| May, 2028 | $17.21 | $15.62 | $18.43 | +1,371% |
| June, 2028 | $16.34 | $14.81 | $18.71 | +1,296% |
| July, 2028 | $20.55 | $16.31 | $21.34 | +1,657% |
| August, 2028 | $15.79 | $14.77 | $22.45 | +1,249% |
| September, 2028 | $13.95 | $13.89 | $17.70 | +1,093% |
| October, 2028 | $8.1495 | $7.7795 | $14.48 | +596.54% |
| November, 2028 | $10.91 | $7.2363 | $13.08 | +832.74% |
| December, 2028 | $14.28 | $9.9764 | $15.03 | +1,120% |
Rapt Therapeutics Inc Stock (RAPT) Price Forecast for 2029
The 2029 price forecast for Rapt Therapeutics Inc Stock (RAPT) is $21.47 on average, with a high prediction of $41.77 and a low estimate of $1.1745. This represents an +1,735% increase from the previous price of $1.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $20.91 | $13.42 | $22.95 | +1,687% |
| February, 2029 | $21.78 | $19.77 | $23.15 | +1,762% |
| March, 2029 | $5.4568 | $3.7401 | $24.22 | +366.39% |
| April, 2029 | $5.2436 | $4.7369 | $6.9502 | +348.17% |
| May, 2029 | $5.047 | $4.467 | $6.5872 | +331.37% |
| June, 2029 | $3.0734 | $2.21 | $5.4904 | +162.68% |
| July, 2029 | $16.34 | $2.5068 | $32.39 | +1,296% |
| August, 2029 | $18.10 | $11.45 | $26.38 | +1,447% |
| September, 2029 | $32.56 | $17.10 | $39.59 | +2,683% |
| October, 2029 | $10.38 | $9.1143 | $41.77 | +787.55% |
| November, 2029 | $10.23 | $1.1745 | $13.50 | +774.18% |
| December, 2029 | $6.6214 | $5.2147 | $12.42 | +465.93% |
Rapt Therapeutics Inc Stock (RAPT) Price Forecast for 2030
Rapt Therapeutics Inc Stock (RAPT) is expected to reach an average price of $18.55 in 2030, with a high forecast of $32.98 and a low forecast of $4.1166. This signifies an +1,485% surge from the last price of $1.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.3684 | $4.1166 | $8.625 | +444.31% |
| February, 2030 | $12.36 | $6.4018 | $15.24 | +956.57% |
| March, 2030 | $18.95 | $11.68 | $26.17 | +1,519% |
| April, 2030 | $12.55 | $12.21 | $21.35 | +972.56% |
| May, 2030 | $17.62 | $12.03 | $19.49 | +1,406% |
| June, 2030 | $19.82 | $16.36 | $29.35 | +1,594% |
| July, 2030 | $24.15 | $17.86 | $32.98 | +1,964% |
| August, 2030 | $7.95 | $5.82 | $26.55 | +579.48% |
| September, 2030 | $14.66 | $8.2034 | $17.07 | +1,153% |
| October, 2030 | $12.22 | $9.9801 | $16.51 | +944.48% |
| November, 2030 | $13.31 | $10.37 | $13.34 | +1,038% |
| December, 2030 | $13.71 | $6.2942 | $14.83 | +1,072% |
0.70%
0.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):